Cell-Based Antibody Screening for Membrane Protein Epitopes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing or screening antibodies against membrane-bound protein antigens are inefficient due to conformational epitope alterations when antigens are solubilized, and existing techniques often select for antibodies with moderate affinity, leading to inclusion of cross-reactive or 'sticky' antibodies, which complicates sequential screening processes.
Innovation Solution
A method involving labeled antigen-expressing cells and labeled antibody-expressing cells is used, where a cell sorter isolates antibody-expressing cells that bind specifically to antigen-expressing cells, allowing for the identification of high-affinity antibodies against conformational epitopes on integral membrane proteins like GPCRs, using sortable labels and cell-based assays.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If soluble antigens are used for antibody preparation, then traditional antibody screening methods can be applied, but conformational epitopes on membrane-bound proteins are altered resulting in failure of antibody preparation
Solution Approach 1:
The patent uses whole cell ELISA to create a functional copy of the membrane-bound protein in its native cellular environment. Instead of solubilizing the protein and risking conformational changes, the method copies the protein's native state by expressing it in whole cells, allowing antibodies to bind to the authentic conformational epitopes without alteration.
Solution Approach 2:
The patent introduces whole cells as an intermediary carrier for membrane-bound proteins. These cells serve as a mediator that preserves the protein's native conformation and presentation, enabling antibody binding to conformational epitopes while avoiding the need for direct protein solubilization that would alter the epitope structure.
2Productivity
If affinity chromatography or immunoblotting methods are used, then antibodies can be selected, but only moderate affinity antibodies are selected leading to inclusion of cross-reactive or sticky antibodies
Solution Approach 1:
The patent replaces traditional mechanical separation methods (affinity chromatography, immunoblotting) with a cell-based functional assay system. Instead of using physical or chemical separation techniques that select for moderate affinity binders, the method uses biological recognition in whole cells to selectively enrich for high affinity antibodies through competitive binding and signal transduction mechanisms.
Solution Approach 2:
The patent changes the selection parameter from antibody binding strength to cellular response magnitude. By measuring the cellular response (e.g., signal transduction, cell surface marker changes) rather than direct antibody-antigen binding strength, the method enables selection of high affinity antibodies that produce amplified biological responses, filtering out cross-reactive and sticky antibodies.
3Reliability
If cells expressing membrane-bound antigens are used directly for antibody preparation, then native conformation is preserved, but an efficient screening method capable of detecting and enriching high affinity antibodies is still lacking
Solution Approach 1:
The patent implements feedback mechanisms through cell-based signal transduction assays. When antibodies bind to membrane proteins on whole cells, the interaction triggers intracellular signaling cascades that produce measurable outputs (e.g., phosphorylation, calcium flux, cell surface marker changes). This feedback amplification allows efficient detection and enrichment of high affinity antibodies based on the magnitude of cellular response.
Solution Approach 2:
The patent makes whole cells serve multiple functions: they act as carriers for membrane proteins, as presentation platforms for epitopes, as signal transduction systems for antibody detection, and as functional readout mechanisms for affinity sorting. This multi-functionality integrates antigen presentation, signal amplification, and selection criteria into a single system, dramatically improving screening efficiency while preserving native conformation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables rapid and efficient identification and isolation of antibodies that specifically bind to cell surface antigens, overcoming the limitations of traditional methods by ensuring high affinity and specificity, particularly for membrane-bound proteins.
Implementation Method 1
separating from the plurality of antibody-expressing cells, one or more antibody-expressing cells that can specifically bind to the antigen-expressing cells using a cell sorter (e.g., a fluorescence activated cell sorter)
Data Source
Figure 1
Figure 2A~2C
Figure 3
AI summary
The invention provides methods for identifying immunobinders, such as scFv antibodies, capable of specifically binding to cell surface antigens, and compositions identified according to said methods.